NEW CAROTID ARTERY STENT PROCEDURE TO BE EVALUATED BY
THE SOCIETY FOR VASCULAR SURGERY PATIENT SAFETY ORGANIZATION
CHICAGO, Illinois, Sept. 9, 2016 -- A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in comparison with carotid endarterectomy (CEA) is being launched by the Society for Vascular Surgery Patient Safety Organization (SVS PSO).
Carotid artery stenting (CAS) and CEA are performed in patients with atherosclerotic narrowing of the carotid artery in order to reduce stroke risk. In the TCAR procedure, a stent is inserted into the common carotid artery through a small neck incision (transcarotid), whereas typical carotid stents are inserted with a long catheter inserted in a groin artery (transfemoral) that must pass through the aorta to reach the carotid artery which is a potential source of stroke with the trans-femoral approach.
During TCAR, stroke risk is also reduced by temporarily reversing blood flow direction in the carotid artery, so that any debris dislodged by the procedure will not travel to the brain where it could cause stroke. Initial publications suggest that TCAR may have a lower stroke rate than standard transfemoral CAS, potentially due to avoidance of a catheter manipulation in the aorta combined with carotid artery flow reversal.
Read More: https://vascular.org/news-advocacy/svs-pso-launches-new-tcar-surveillance-project
Edward R Jones, MD, MBA, FACP LaRhondd James, RN Sophid Rosen, PhD
OncoMed Pharmaceuticals Completes Enrollment of Phase 2 YOSEMITE Clinical Trial of Demcizumab in Pancreatic Cancer
Results Expected in the First Half of 2017
NN&I interviewed Leslie Trigg, CEO of Outset Medical, on the company's new Tablo dialysis machine, which is aimed at clinics who want to develop the self-care option for patients.
By: Sarah S. Prichard, MD, FRCP(C) Glenn M. Chertow, MD, MPH
Innovator: Leslie Trigg
MedtechVision 2016: Global Medtech
Via: MedCity News
Last week, Omada Health, a San Francisco digital health startup, announced that it is partnering with the American Medical Association and Intermountain Healthcare, the Salt Lake City, Utah-based health system, to prevent the onset of diabetes in adult patients.
Via: IV Post
The American Medical Association (AMA), Omada Health, and Intermountain Healthcare today announced an innovative initiative aimed at reducing the alarming number of adults who develop type 2 diabetes. The new collaboration will create a roadmap for large health care organizations across the country to adopt proven online behavior change interventions for at-risk patients, and integrate those programs into provider referral and clinical workflow.
NEW YORK, New York (26 July 2016) – Today, Interbrand launches the inaugural Interbrand Breakthrough Brands report, in partnership with Facebook, Ready Set Rocket, and the New York Stock Exchange (NYSE). The Interbrand Breakthrough Brands report, entitled “Future Growth,” is unique in that it examines emerging companies that are brand-led—organizations that have both unique business models and strong brands. The report complements Interbrand’s annual Best Global Brands report, now entering its 17th year, by putting a spotlight on emerging brands—especially those that are affecting change and embodying growth.